Avidity Biosciences
RNAM
#1863
Rank
A$16.24 B
Marketcap
A$105.18
Share price
0.00%
Change (1 day)
35.81%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Last known market cap: A$16.24 Billion

As of November 2026 Avidity Biosciences has a market cap of A$16.24 Billion. This makes Avidity Biosciences the world's 1863th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026A$16.24 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$240.64 B 1,381.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$149.22 B 818.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$2.67 B-83.57%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
A$7.84 B-51.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.34 B-97.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.18 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
A$15.78 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$5.56 B-65.73%๐Ÿ‡บ๐Ÿ‡ธ USA